Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Triple Negative Breast Neoplasms 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Advanced Gastric Adenocarcinoma 2Solid Tumor 1Small Cell Lung Carcinoma 1Small Cell Lung Cancer Extensive Stage 1Sarcoma 1NSCLC 1Mucosal Melanoma 1Esophageal Squamous Cell Carcinoma 1Esophageal Diseases 1Drug-Related Side Effects and Adverse Reactions 1Digestive System Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

camrelizumab 1apatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Mucosal Melanoma × camrelizumab × Clear all
NCT03986515 2019-06-14

Apatinib Plus SHR1210 in Advanced Mucosal Melanoma

Henan Cancer Hospital

Phase 2 Unknown
40 enrolled
Dermatologic

Mucosal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡